Clinical Trials Browser

Phase 2 × Lymphoma, Mantle-Cell × tanespimycin × Clear all

NCT00117988 2014-05-30

17-AAG in Treating Patients With Relapsed or Refractory Anaplastic Large Cell Lymphoma, Mantle Cell Lymphoma, or Hodgkin's Lymphoma

Phase 2 Completed

22 enrolled 5 charts

Lymphoid

Hodgkin Disease, Lymphoma, Large-Cell, Anaplastic, Lymphoma, Mantle-Cell

NCT00132015 2012-03-15

17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Systemic Mastocytosis

Phase 2 Completed

37 enrolled

LymphoidMyeloidOther hematologic neoplasmOther neoplasm

Multi-centric Castleman's Disease, Angiolymphoid Hyperplasia with Eosinophilia, Burkitt Lymphoma, Leukemia, Leukemia, Hairy Cell, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Monoclonal Gammopathy of Undetermined Significance, Myeloproliferative Disorders, Polycythemia Vera, Precancerous Conditions, Thrombocythemia, Essential, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma